2 resultados para Hospitalized Adults
em Repositório Científico do Instituto Politécnico de Lisboa - Portugal
Resumo:
Perda auditiva: elevada prevalência da perda auditiva (14,1%), efeitos na comunicação, efeitos em aspectos psicossociais, cognitivos, da fala e linguagem. Avaliação da perda auditiva: baseia-se nos testes audiométricos psicoacústicos, base audiometria tonal, que permite estimar a sensibilidade auditiva (normal vs anormal), permite classificar o tipo e grau de perda auditiva, avaliação qualitativa com a utilização de escalas desenvolvidas para esse efeito, HHIA (Hearing Handicap Inventory for Adults), instrumento desenvolvido a partir do HHIE (Hearing Handicap Inventory for the Elderly), para ser usado com pacientes de idade inferior a 65 anos.
Resumo:
The Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymatic defect in the world. The most common clinical manifestations are acute hemolytic anemia associated with drugs, infections, neonatal jaundice and hemolytic non-spherocytic chronic anemia. The main aim of this study was to determine the frequency of major genetic variants of G6PD leading to enzyme deficiency in children from 0 to 14 years at a Pediatric Hospital in Luanda, Angola. A cross-sectional and descriptive analytical study covered a total of 194 children aged from 0 to 14 years, of both genders and hospitalized at the Pediatric Hospital David Bernardino, Luanda between November and December, 2011. The G202A, A376G and C563T mutations of the G6PD gene were determined by real-time PCR with Taqman probes. The disabled A-/A- genotype was detected in 10 girls (10.9%). Among the boys, 21 (20.6%) presented the genotype A-. Considering all the samples, the A- variant was observed in 22.4% of cases. The Mediterranean mutation was not detected in the Angolan sample. Furthermore, no association was found between genotype and anemia, nutritional state and mucosa color. A significant association, however, was observed with jaundice. Based on the results obtained, there is a clear need to identify those with the disabled genotype in the Angolan population in order to avoid cases of drug-induced anemia, particularly in the treatment of malaria, so prevalent in Angola.